How will medicine e-commerce develop in 2020?

[pharmaceutical network market analysis] medicine has always been a strong regulatory field, and any agitation of policies will affect the development direction of the industry In 2019, the second revised "Drug Administration Law" came to the ground after several twists and turns Although the published version did not make any detailed description of online prescription drugs, it also did not explicitly "prohibit online sale of prescription drugs" as before, which brought sufficient imagination space for pharmaceutical e-commerce Therefore, the Discussion on online prescription drugs rules almost ran through the whole year of 2019 The time has come to 2020, and how the pharmaceutical e-commerce will develop has become a hot topic To this end, the author specially consulted a number of industry insiders, based on their judgments and opinions, hoping to see the development trend of the pharmaceutical e-commerce industry in 2020 Prescription drug compliance drives growth, but also ushers in strict supervision In fact, there is no essential difference between pharmaceutical e-commerce and ordinary e-commerce The important difference lies in the pharmaceutical field: first, it is subject to strict supervision, and second, it requires higher service requirements than other e-commerce fields In recent years, with the gradual deregulation of policies, like most other sunrise industries, the development of pharmaceutical e-commerce is becoming more and more rapid According to some analysis, thanks to the favorable policies such as online prescription drug compliance, the linkage between medical e-commerce and hospitals, and the increasing acceptance of medical e-commerce by consumers, medical e-commerce is expected to return to rapid growth In 2020, the market size of Chinese medical e-commerce will reach 175.6 billion yuan, with a market increase of 90 billion yuan But at the same time, with the increase of the market, strict regulation of prescriptions, implementation of the prescription and the system of the person in charge of the examination will become an important measure; in addition, although the pharmaceutical e-commerce can optimize the resources and utilization rate of pharmacists through the Internet technology, and effectively solve the industry pain of the shortage of offline pharmacists, the qualification examination of pharmacists will also be strictly checked Medical + medicine + payment will usher in great development in the past The imperfection of medical insurance payment system, the inability of online consumption to use medical insurance payment, and the inability of medical insurance co-ordination account to be used for retail payment restrict the development of medical e-commerce In addition, due to the strict supervision of medical insurance, online drug purchase cannot use medical insurance payment, which limits the online consumption of some consumers, is not conducive to improving the online shopping experience of consumers, and to a certain extent hinders the development of medical e-commerce However, based on the guidance on improving the "Internet plus" medical service price and medical insurance payment policy issued by the State Health Insurance Bureau in 2019, the insiders believe that in 2020, the closed-loop of "medical + drug + payment" is expected to usher in a breakthrough In fact, the entry of Internet giants intensifies the competition At present, several kinds of development models of China's pharmaceutical e-commerce have been found out from years of barbaric growth or from the scuffle The four common types include B2B, B2C, o2o and DTP But as more and more giants or other new competitors join in the future, it will bring more innovative development path to the industry, and the competition will be more and more fierce Insiders believe that Internet giants will continue to complete the layout of the whole industrial chain in the future, from online diagnosis and treatment, o2o distribution, and offline stores More innovative retail models and enterprises will emerge In fact, at present, the main way of pharmaceutical supply chain innovation in China is to closely integrate with the Internet, take informatization as the main driving force, highly integrate all kinds of medical resources, promote multi-element integrated innovation, and achieve pharmaceutical supply chain coordination However, at present, the development mode of pharmaceutical e-commerce in China is still in the exploratory stage Although there are many kinds of supply chain modes, there are still problems such as low industry concentration, asymmetric information between each node of the supply chain, and high enterprise operation cost However, as consumers are eager for more convenient and safe access to drugs, Internet +, big data analysis and other technologies provide technical support for the development of new medicine retail, and relevant national policies provide strong support for the development of new medicine retail In 2020, more pharmaceutical retail models and enterprises may begin to enter the field of vision.